Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 18, 2022 | Post-IPO Equity | $200M | 1 | — | — | Detail |
Jul 29, 2020 | Series C | $121M | 1 | — | — | Detail |
Aug 30, 2019 | Series B | $120M | 1 | — | — | Detail |